Related Experiment Video
Updated: Feb 27, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Protective function of SLC30A10 induced via PERK-ATF4 pathway against 1-methyl-4-phenylpyridinium
Suzuna Go1, Hisaka Kurita1, Kazuki Yokoo1
1Laboratory of Medical Therapeutics and Molecular Therapeutics, Department Biomedical Pharmaceutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi Gifu City, Gifu 501-1196, Japan.
Abstract:
Solute carrier family 30 member 10 (SLC30A10) has been known as manganese transporter. It has been suggested that neurodegenerative diseases are related with cellular stress such as oxidative stress or endoplasmic reticulum (ER) stress. However, it remains unknown whether SLC30A10 is actually involved in several intracellular stress. We found that the level of Slc30a10 was increased in midbrain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Therefore, we further investigated the role of SLC30A10 in the 1-methyl-4-phenylpiridium ion (MPP+)-induced intracellular stress, and the molecular mechanism underlying SLC30A10 induction by MPP+ treatment. In human neuroblastoma cell line (SH-SY5Y) treated with MPP+ (1 mM), the SLC30A10 mRNA level was significantly increased, and in addition, the expression of CHOP, which is known as one of ER stress markers, was significantly increased by MPP+. Interestingly, the level of SLC30A10 mRNA was significantly increased by tunicamycin as an ER stressor, suggesting that the induction of SLC30A10 by MPP+ was caused via ER stress. Considering that PKR-like endoplasmic reticulum kinase (PERK) pathway is activated under ER stress induced by MPP+, we investigated whether the expression of SLC30A10 is increased through ATF4, which is major transcription factor in PERK pathway. The increase of SLC30A10 expression in MPP+-treated cells was eliminated by ATF4 knockdown. And the protective role of SLC30A10 against MPP+-induced ER stress was confirmed by measuring cell viability in SLC30A10 knockdown cells. In conclusion, SLC30A10 is thought to have protective role for MPP+-induced toxicity via PERK-ATF4 pathway.
Insights
Solute carrier family 30 member 10 (SLC30A10) protects against 1-methyl-4-phenylpiridium ion (MPP+) induced neurotoxicity. This manganese transporter is upregulated via ER stress and the PERK-ATF4 pathway, mitigating cellular damage.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Neurodegenerative diseases are linked to cellular stress, including oxidative and endoplasmic reticulum (ER) stress.
- The role of manganese transporter Solute Carrier Family 30 Member 10 (SLC30A10) in intracellular stress responses remains unclear.
- Slc30a10 levels increase in the midbrain of MPTP-treated mice, suggesting a potential role in neurotoxicity.
Purpose of the Study:
- To investigate the involvement of SLC30A10 in 1-methyl-4-phenylpiridium ion (MPP+)-induced intracellular stress.
- To elucidate the molecular mechanism underlying SLC30A10 induction by MPP+ treatment.
- To determine the protective role of SLC30A10 against MPP+-induced neurotoxicity.
Main Methods:
- MPP+ treatment of human neuroblastoma SH-SY5Y cells.
- Analysis of SLC30A10 and ER stress marker (CHOP) mRNA levels.
- Tunicamycin treatment to induce ER stress.
- Investigation of the PERK-ATF4 pathway, including ATF4 knockdown.
- Cell viability assays in SLC30A10 knockdown cells.
Main Results:
- MPP+ treatment significantly increased SLC30A10 and CHOP mRNA levels in SH-SY5Y cells.
- ER stress induced by tunicamycin also upregulated SLC30A10 mRNA, suggesting MPP+ acts via ER stress.
- SLC30A10 induction by MPP+ was dependent on the PERK-ATF4 pathway, as ATF4 knockdown abolished the increase.
- SLC30A10 knockdown exacerbated MPP+-induced ER stress and reduced cell viability.
Conclusions:
- SLC30A10 is upregulated in response to MPP+-induced ER stress through the PERK-ATF4 pathway.
- SLC30A10 plays a protective role against MPP+-induced neurotoxicity by mitigating ER stress.
- These findings highlight SLC30A10 as a potential therapeutic target for neurodegenerative conditions involving ER stress.
More Related Videos
09:02Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
10:50Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
The Unfolded Protein Response